title: The effects of an olmesartan medoxomil-based treatment algorithm on 24-hour blood pressure levels in elderly patients aged 65 and older.
abstract: This study examined the effect of olmesartan medoxomil (OM) +/- hydrochlorothiazide (HCTZ) on mean 24-hour ambulatory blood pressure, mean seated cuff (Se) blood pressure (BP), and SeBP goal achievement in elderly (65 years and older) patients with hypertension. After a 2- to 3-week placebo run-in period, patients received OM 20 mg, up-titrated to OM 40 mg, and then added HCTZ 12.5 mg to 25 mg in a stepwise manner at 3-week intervals if SeBP remained >or=120/70 mm Hg. The primary end point was change from baseline in mean 24-hour ambulatory systolic BP. At study end, mean 24-hour ambulatory BP had decreased by 25.7/12.3 mm Hg (n=150) and mean SeBP by 25.4/10.5 mm Hg (n=176; all P<.00001 vs baseline). Drug-related treatment-emergent adverse events, most commonly dizziness (3.4%), hypotension (2.2%), and headache (1.1%), were observed in 11.8% of patients. An OM-based treatment algorithm effectively lowers BP in an elderly patient population throughout the 24-hour dosing interval without compromising tolerability.
authors.affiliation: The Christ Hospital Heart and Vascular Center and the Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH, USA.
authors.forename: Dean J
authors.initials: DJ
authors.lastname: Kereiakes
authors.forename: Joel
authors.initials: J
authors.lastname: Neutel
authors.forename: Kathy A
authors.initials: KA
authors.lastname: Stoakes
authors.forename: William F
authors.initials: WF
authors.lastname: Waverczak
authors.forename: Jianbo
authors.initials: J
authors.lastname: Xu
authors.forename: Ali
authors.initials: A
authors.lastname: Shojaee
authors.forename: Robert
authors.initials: R
authors.lastname: Dubiel
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D018660:Blood Pressure Monitoring, Ambulatory / Q000379:methods; D002940:Circadian Rhythm / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D007093:Imidazoles / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D000068557:Olmesartan Medoxomil; D016037:Single-Blind Method; D013777:Tetrazoles / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D007093:Imidazoles; D013777:Tetrazoles; D000068557:Olmesartan Medoxomil
references.citation: J Hum Hypertens. 2006 Mar;20(3):177-85
references.pmid: 16306998
references.citation: N Engl J Med. 2003 Feb 13;348(7):583-92
references.pmid: 12584366
references.citation: Hypertension. 2007 Jan;49(1):69-75
references.pmid: 17159087
references.citation: Age Ageing. 2008 Mar;37(2):201-6
references.pmid: 18349014
references.citation: J Hypertens. 2007 Oct;25(10):2168-77
references.pmid: 17885562
references.citation: Ann Intern Med. 2001 Nov 6;135(9):825-34
references.pmid: 11694107
references.citation: JAMA. 1999 Aug 11;282(6):539-46
references.pmid: 10450715
references.citation: Hypertension. 2001 Mar;37(3):869-74
references.pmid: 11244010
references.citation: J Clin Hypertens (Greenwich). 2004 Apr;6(4):168-74
references.pmid: 15073470
references.citation: J Clin Hypertens (Greenwich). 2008 Dec;10(12):911-21
references.pmid: 19120717
references.citation: BMJ. 1992 Feb 15;304(6824):405-12
references.pmid: 1445513
references.citation: Lancet. 1998 Jun 13;351(9118):1755-62
references.pmid: 9635947
references.citation: Circulation. 1997 Jul 1;96(1):308-15
references.pmid: 9236450
references.citation: Br Med J (Clin Res Ed). 1986 Nov 1;293(6555):1145-51
references.pmid: 3094811
references.citation: Ann Intern Med. 1999 Mar 16;130(6):461-70
references.pmid: 10075613
references.citation: Blood Press Monit. 2004 Apr;9(2):91-7
references.pmid: 15096906
references.citation: Arch Intern Med. 1999 Jun 14;159(11):1205-12
references.pmid: 10371228
references.citation: J Clin Hypertens (Greenwich). 2007 Jan;9(1):36-44
references.pmid: 17215657
references.citation: BMJ. 2008 May 17;336(7653):1121-3
references.pmid: 18480116
references.citation: J Hypertens. 2004 Jun;22(6):1113-8
references.pmid: 15167445
references.citation: Vasc Health Risk Manag. 2005;1(2):163-9
references.pmid: 17315403
references.citation: Circulation. 2005 Feb 8;111(5):697-716
references.pmid: 15699287
references.citation: Lancet. 1985 Jun 15;1(8442):1349-54
references.pmid: 2861311
references.citation: Blood Press Monit. 2001 Dec;6(6):355-70
references.pmid: 12055415
references.citation: Am J Hypertens. 2005 Feb;18(2 Pt 1):287-94
references.pmid: 15752958
references.citation: Circulation. 1989 Apr;79(4):733-43
references.pmid: 2647318
references.citation: Lancet. 1991 Nov 23;338(8778):1281-5
references.pmid: 1682683
references.citation: Hypertension. 2003 Dec;42(6):1206-52
references.pmid: 14656957
references.citation: Lancet. 2002 Dec 14;360(9349):1903-13
references.pmid: 12493255
references.citation: J Clin Hypertens (Greenwich). 2008 Apr;10(4):272-9
references.pmid: 18401224
references.citation: Circulation. 2003 Mar 18;107(10):1401-6
references.pmid: 12642361
references.citation: N Engl J Med. 2008 May 1;358(18):1887-98
references.pmid: 18378519
references.citation: J Am Geriatr Soc. 2007 Jul;55(7):1056-65
references.pmid: 17608879
references.citation: J Clin Hypertens (Greenwich). 2008 Jan;10(1 Suppl 1):33-9
references.pmid: 18174782
references.citation: N Engl J Med. 2006 Jun 1;354(22):2368-74
references.pmid: 16738273
references.citation: Hypertension. 2006 Mar;47(3):345-51
references.pmid: 16432045
references.citation: Hypertens Res. 2008 Jan;31(1):43-50
references.pmid: 18360017
references.citation: Clin Ther. 2003 Nov;25(11):2765-80
references.pmid: 14693303
references.citation: Am J Med. 2008 Mar;121(3):179-184.e3
references.pmid: 18328297
references.citation: J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):393-404
references.pmid: 12461301
references.citation: Clin Ther. 2003 May;25(5):1469-89
references.pmid: 12867222
references.citation: Am J Hypertens. 2005 Feb;18(2 Pt 1):149-51
references.pmid: 15752939